BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1577396)

  • 1. Advances in the therapy of cholestatic liver disease.
    Roda E; Parini P; Bazzoli F; Mazzella G; Festi D; Aldini R
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():53-5. PubMed ID: 1577396
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1989 May; 9(2):138-43. PubMed ID: 2658104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 4. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
    Schmidt HH; Manns MP
    Am J Gastroenterol; 1996 Feb; 91(2):406-7. PubMed ID: 8607528
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of cholestatic hepatopathies].
    Leuschner U
    Schweiz Rundsch Med Prax; 1992 Aug; 81(34):983-4. PubMed ID: 1529191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid for the treatment of cholestatic diseases.
    Poupon RE; Poupon R
    Prog Liver Dis; 1992; 10():219-38. PubMed ID: 1296231
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.
    Abbas G; Lindor KD
    Expert Opin Pharmacother; 2010 Feb; 11(3):387-92. PubMed ID: 20102304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of cholestatic liver disease and therapeutic approaches.
    Hirschfield GM; Heathcote EJ; Gershwin ME
    Gastroenterology; 2010 Nov; 139(5):1481-96. PubMed ID: 20849855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of primary biliary cirrhosis. Its current status].
    Berenguer Lapuerta J; Nos Mateu P; Siles Moreno MS
    Rev Esp Enferm Dig; 1991 Nov; 80(5):324-30. PubMed ID: 1768472
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary biliary cirrhosis.
    Gong Y; Christensen E; Gluud C
    N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for therapy with ursodeoxycholic acid in patients with cholestatic liver disease.
    van Erpecum KJ; van de Meeberg PC; van Berge Henegouwen GP
    Neth J Med; 1993 Dec; 43(5-6):233-8. PubMed ID: 8107930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotic therapy of liver cirrhosis, with special reference to primary biliary cirrhosis: promises and limitations.
    Jansen PL
    Neth J Med; 1992 Apr; 40(3-4):209-14. PubMed ID: 1603214
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of primary biliary cirrhosis and cholestatic disorders with ursodeoxycholic acid.
    Leuschner U; Kurtz W
    Lancet; 1987 Aug; 2(8557):508. PubMed ID: 2887794
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
    Kaplan MM; Poupon R
    Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.